99 related articles for article (PubMed ID: 16731604)
1. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
[TBL] [Abstract][Full Text] [Related]
2. Correlation between cathepsin D expression and p53 protein nuclear accumulation in oesophageal squamous cell carcinoma.
Ikeguchi M; Sakatani T; Ueta T; Fukuda K; Oka S; Hisamitsu K; Yamaguchi K; Tsujitani S; Kaibara N
J Clin Pathol; 2002 Feb; 55(2):121-6. PubMed ID: 11865007
[TBL] [Abstract][Full Text] [Related]
3. Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium.
Cook MB; Barnett MJ; Bock CH; Cross AJ; Goodman PJ; Goodman GE; Haiman CA; Khaw KT; McCullough ML; Newton CC; Boutron-Ruault MC; Lund E; Rutegård M; Thornquist MD; Spriggs M; Giffen C; Freedman ND; Kemp T; Kroenke CH; Le Marchand L; Park JY; Simon M; Wilkens LR; Pinto L; Hildesheim A; Campbell PT
Gut; 2019 Jun; 68(6):960-968. PubMed ID: 30121626
[TBL] [Abstract][Full Text] [Related]
4. Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582.
Chaube A; Tewari M; Garbyal RS; Singh U; Shukla HS
BMC Cancer; 2006 May; 6():126. PubMed ID: 16686942
[TBL] [Abstract][Full Text] [Related]
5. Ductal adenocarcinoma of the pancreas: Expression of growth factor receptors, oncogenes and suppressor genes, and their relationship to pathological features, staging and survival.
Lozano-Leon A; Perez-Quintela BV; Iglesias-García J; Lariño-Noia J; Varo E; Forteza J; Domínguez-Muñoz JE
Oncol Lett; 2011 Jan; 2(1):161-166. PubMed ID: 22870146
[TBL] [Abstract][Full Text] [Related]
6. Causal Link of Human Papillomavirus in Barrett Esophagus and Adenocarcinoma: Are We There Yet?
Rajendra S; Sharma P
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765833
[TBL] [Abstract][Full Text] [Related]
7. High expression of tumor susceptibility gene 101 (TSG101) is associated with more aggressive behavior in colorectal carcinoma.
Gheytanchi E; Saeednejad Zanjani L; Ghods R; Abolhasani M; Shahin M; Vafaei S; Naseri M; Fattahi F; Madjd Z
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1631-1646. PubMed ID: 33616717
[TBL] [Abstract][Full Text] [Related]
8. Overexpression and translocation of dynamin 2 promotes tumor aggressiveness in breast carcinomas.
Sajed R; Saeednejad Zanjani L; Rahimi M; Mansoori M; Zarnani AH; Madjd Z; Ghods R
EXCLI J; 2020; 19():1423-1435. PubMed ID: 33250680
[TBL] [Abstract][Full Text] [Related]
9. Genomics and Targeted Therapies in Gastroesophageal Adenocarcinoma.
Nagaraja AK; Kikuchi O; Bass AJ
Cancer Discov; 2019 Dec; 9(12):1656-1672. PubMed ID: 31727671
[TBL] [Abstract][Full Text] [Related]
10. Precision medicine in gastric cancer.
Bonelli P; Borrelli A; Tuccillo FM; Silvestro L; Palaia R; Buonaguro FM
World J Gastrointest Oncol; 2019 Oct; 11(10):804-829. PubMed ID: 31662821
[TBL] [Abstract][Full Text] [Related]
11. From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.
Caspa Gokulan R; Garcia-Buitrago MT; Zaika AI
Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):37-48. PubMed ID: 31152823
[TBL] [Abstract][Full Text] [Related]
12. Cetuximab for esophageal cancer: an updated meta-analysis of randomized controlled trials.
Huang ZH; Ma XW; Zhang J; Li X; Lai NL; Zhang SX
BMC Cancer; 2018 Nov; 18(1):1170. PubMed ID: 30477458
[TBL] [Abstract][Full Text] [Related]
13. A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas.
Creemers A; Ebbing EA; Pelgrim TC; Lagarde SM; van Etten-Jamaludin FS; van Berge Henegouwen MI; Hulshof MCCM; Krishnadath KK; Meijer SL; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
Sci Rep; 2018 Sep; 8(1):13281. PubMed ID: 30185893
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis.
Zhang Z; Tang H; Lin J; Hu Y; Luo G; Luo Z; Cheng C; Wang P
Oncotarget; 2017 Mar; 8(10):17202-17215. PubMed ID: 28199988
[TBL] [Abstract][Full Text] [Related]
15. EGFR family and cMet expression profiles and prognostic significance in esophagogastric adenocarcinoma.
Chan E; Alkhasawneh A; Duckworth LV; Aijaz T; Toro TZ; Lu X; Hughes SJ; Collinsworth A; George TJ
J Gastrointest Oncol; 2016 Dec; 7(6):838-847. PubMed ID: 28078108
[TBL] [Abstract][Full Text] [Related]
16. Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial.
Tebbutt NC; Price TJ; Ferraro DA; Wong N; Veillard AS; Hall M; Sjoquist KM; Pavlakis N; Strickland A; Varma SC; Cooray P; Young R; Underhill C; Shannon JA; Ganju V; Gebski V
Br J Cancer; 2016 Mar; 114(5):505-9. PubMed ID: 26867157
[TBL] [Abstract][Full Text] [Related]
17. Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma.
McCormick Matthews LH; Noble F; Tod J; Jaynes E; Harris S; Primrose JN; Ottensmeier C; Thomas GJ; Underwood TJ
Br J Cancer; 2015 Jun; 113(1):107-18. PubMed ID: 26110972
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of Barrett's esophagus.
Fouad YM; Mostafa I; Yehia R; El-Khayat H
World J Gastrointest Pathophysiol; 2014 Nov; 5(4):450-6. PubMed ID: 25400988
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy.
Aichler M; Motschmann M; Jütting U; Luber B; Becker K; Ott K; Lordick F; Langer R; Feith M; Siewert JR; Walch A
Oncotarget; 2014 Aug; 5(16):6620-32. PubMed ID: 25216514
[TBL] [Abstract][Full Text] [Related]
20. Multi-colour FISH in oesophageal adenocarcinoma-predictors of prognosis independent of stage and grade.
Geppert CI; Rümmele P; Sarbia M; Langer R; Feith M; Morrison L; Pestova E; Schneider-Stock R; Hartmann A; Rau TT
Br J Cancer; 2014 Jun; 110(12):2985-95. PubMed ID: 24853183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
